A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer

Journal of Proteome Research

Volumn 13, Issue 11, 2014, Pages 4995-5007

  Boichenko, Alexander P ^a   Govorukhina, Natalia ^a   Klip, Harry G ^b   Van Der Zee, A G J ^b   Güzel, Coşkun ^c   Luider, Theo M ^c   Bischoff, Rainer ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

alpha 1 acid glycoprotein; alpha 1 antitrypsin; alpha 2 HS glycoprotein; cervical cancer; cervical intraepithelial neoplasia; haptoglobin; LC MS MS; protein panel; serotransferrin; vitamin D binding protein

Indexed keywords

ALPHA 1 ANTITRYPSIN; FETUIN A; HAPTOGLOBIN; OROSOMUCOID; TRANSFERRIN; VITAMIN D BINDING PROTEIN; PLASMA PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; EARLY CANCER; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CERVICAL CANCER; TANDEM MASS SPECTROMETRY; TRANSFERRIN BLOOD LEVEL; TUBE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; AMINO ACID SEQUENCE; BLOOD; CASE CONTROL STUDY; ISOTOPE LABELING; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PROCEDURES; PROTEOMICS; REFERENCE VALUE; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADULT; AGED; AMINO ACID SEQUENCE; BLOOD PROTEINS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; ISOTOPE LABELING; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEOMICS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84908891786     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500601w     Document Type: Article

References (55)

1. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002 Ca-Cancer J. Clin. 2005, 55 (2) 74-108
2. Li, J.; Cheng, H.; Zhang, P.; Dong, Z.; Tong, H.-l.; Jackie Han, J. D.; Guo, F.; Tian, Y.-p. Prognostic value of combined serum biomarkers in predicting outcomes in cervical cancer patients Clin. Chim. Acta 2013, 424 (0) 292-297
3. Nijhuis, E. R.; Reesink-Peters, N.; Wisman, G. B. A.; Nijman, H. W.; Van Zanden, J.; Volders, H.; Hollema, H.; Suurmeijer, A. J. H.; Schuuring, E.; Van Der Zee, A. G. J. An overview of innovative techniques to improve cervical cancer screening Cell. Oncol. 2006, 28 (5-6) 233-246
4. Arbyn, M.; Verdoodt, F.; Snijders, P. J. F.; Verhoef, V. M. J.; Suonio, E.; Dillner, L.; Minozzi, S.; Bellisario, C.; Banzi, R.; Zhao, F.-H.; Hillemanns, P.; Anttila, A. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis Lancet Oncol. 2014, 15 (2) 172-183
5. Hanash, S. M.; Pitteri, S. J.; Faca, V. M. Mining the plasma proteome for cancer biomarkers Nature 2008, 452 (7187) 571-579
6. Farrah, T.; Deutsch, E. W.; Omenn, G. S.; Campbell, D. S.; Sun, Z.; Bletz, J. A.; Mallick, P.; Katz, J. E.; Malmström, J.; Ossola, R.; Watts, J. D.; Lin, B.; Zhang, H.; Moritz, R. L.; Aebersold, R., A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 2011, 10, (9).
7. Boichenko, A. P.; Govorukhina, N.; van der Zee, A. G. J.; Bischoff, R. Multidimensional separation of tryptic peptides from human serum proteins using reversed-phase, strong cation exchange, weak anion exchange, and fused-core fluorinated stationary phases J. Sep. Sci. 2013, 36 (21-22) 3463-3470
8. Kato, H.; Torigoe, T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma Cancer 1977, 40 (4) 1621-1628
9. Goldenberg, D. M.; DeLand, F.; Kim, E. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning New Engl. J. Med. 1978, 298 (25) 1384-1388
10. Inoue, M.; Inoue, Y.; Hiramatsu, K.; Ueda, G. The clinical value of tissue polypeptide antigen in patients with gynecologic tumors Cancer 1985, 55 (11) 2618-2623
11. Gadducci, A.; Cosio, S.; Carpi, A.; Nicolini, A.; Genazzani, A. R. Serum tumor markers in the management of ovarian, endometrial and cervical cancer Biomed. Pharmacother. 2004, 58 (1) 24-38
12. Gadducci, A.; Tana, R.; Cosio, S.; Genazzani, A. R. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: A review of the literature Crit. Rev. Oncol./Hematol. 2008, 66 (1) 10-20
13. Abdul-Rahman, P. S.; Lim, B. K.; Hashim, O. H. Expression of high-abundance proteins in sera patients with endometrial and cervical cancers: Analysis using 2-DE with silver staining and lectin detection methods Electrophoresis 2007, 28 (12) 1989-1996
14. Looi, M. L.; Karsani, S. A.; Rahman, M. A.; Dali, A. Z.; Ali, S. A.; Ngah, W. Z.; Yusof, Y. A. Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma J. Biosci. 2009, 34 (6) 917-925
15. Bhattacharyya, J.; Chaudhuri, L. α1-Antitrypsin: A possible tool for diagnosis of cervical cancer Biochem. Med. Metabol. Biol. 1990, 43 (3) 243-245
16. Woodman, C. B. J.; Collins, S. I.; Young, L. S. The natural history of cervical HPV infection: unresolved issues Nat. Rev. Cancer 2007, 7 (1) 11-22
17. Boichenko, A.; Govorukhina, N.; Zee, A. J.; Bischoff, R. Simultaneous serum desalting and total protein determination by macroporous reversed-phase chromatography Anal. Bioanal. Chem. 2013, 1-9
18. Keller, A.; Nesvizhskii, A. I.; Kolker, E.; Aebersold, R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal. Chem. 2002, 74 (20) 5383-5392
19. Nesvizhskii, A. I.; Keller, A.; Kolker, E.; Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry Anal. Chem. 2003, 75 (17) 4646-4658
20. Shadforth, I. P.; Dunkley, T. P. J.; Lilley, K. S.; Bessant, C. i-Tracker: For quantitative proteomics using iTRAQ BMC Genomics 2005, 6, 145 10.1021/pr500601w 1535-3893
21. Mosteller, F.; Fisher, R. A. Questions and Answers Am. Stat. 1948, 2 (5) 30-31
22. Kohlbacher, O.; Reinert, K.; Gropl, C.; Lange, E.; Pfeifer, N.; Schulz-Trieglaff, O.; Sturm, M. TOPP-the OpenMS proteomics pipeline Bioinformatics 2007, 23 (2) e191-7
23. Sturm, M.; Bertsch, A.; Gropl, C.; Hildebrandt, A.; Hussong, R.; Lange, E.; Pfeifer, N.; Schulz-Trieglaff, O.; Zerck, A.; Reinert, K.; Kohlbacher, O. OpenMS-An open-source software framework for mass spectrometry BMC Bioinformatics 2008, 9 (1) 163
24. Sas, G.; Pepper, D. S.; Cash, J. D. Investigations on Antithrombin III in Normal Plasma and Serum Br. J. Hamaetol. 1975, 30 (3) 265-272
25. Neunteufel, W.; Tatra, G.; Bieglmayer, C. Serum squamous cell carcinoma antigen levels in women with neoplasms of the lower genital tract and in healthy controls Arch. Gynecol. Obstet. 1989, 246 (4) 243-250
26. Duk, J. M.; de Bruijn, H. W. A.; Groenier, K. H.; Hollema, H.; Ten Hoor, K. A.; Krans, M.; Aalders, J. G. Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determinations Gynecol. Oncol. 1990, 39, 186-194
27. Mischak, H.; Allmaier, G.; Apweiler, R.; Attwood, T.; Baumann, M.; Benigni, A.; Bennett, S. E.; Bischoff, R.; Bongcam-Rudloff, E.; Capasso, G.; Coon, J. J.; DHaese, P.; Dominiczak, A. F.; Dakna, M.; Dihazi, H.; Ehrich, J. H.; Fernandez-Llama, P.; Fliser, D.; Frokiaer, J.; Garin, J.; Girolami, M.; Hancock, W. S.; Haubitz, M.; Hochstrasser, D.; Holman, R. R.; Ioannidis, J. P. A.; Jankowski, J.; Julian, B. A.; Klein, J. B.; Kolch, W.; Luider, T.; Massy, Z.; Mattes, W. B.; Molina, F.; Monsarrat, B.; Novak, J.; Peter, K.; Rossing, P.; Sánchez-Carbayo, M.; Schanstra, J. P.; Semmes, O. J.; Spasovski, G.; Theodorescu, D.; Thongboonkerd, V.; Vanholder, R.; Veenstra, T. D.; Weissinger, E.; Yamamoto, T.; Vlahou, A. Recommendations for Biomarker Identification and Qualification in Clinical Proteomics Sci. Transl. Med. 2010, 2 (46) 46ps42
28. Mischak, H.; Ioannidis, J. P. A.; Argiles, A.; Attwood, T. K.; Bongcam-Rudloff, E.; Broenstrup, M.; Charonis, A.; Chrousos, G. P.; Delles, C.; Dominiczak, A.; Dylag, T.; Ehrich, J.; Egido, J.; Findeisen, P.; Jankowski, J.; Johnson, R. W.; Julien, B. A.; Lankisch, T.; Leung, H. Y.; Maahs, D.; Magni, F.; Manns, M. P.; Manolis, E.; Mayer, G.; Navis, G.; Novak, J.; Ortiz, A.; Persson, F.; Peter, K.; Riese, H. H.; Rossing, P.; Sattar, N.; Spasovski, G.; Thongboonkerd, V.; Vanholder, R.; Schanstra, J. P.; Vlahou, A. Implementation of proteomic biomarkers: making it work Eur. J. Clin. Invest. 2012, 42 (9) 1027-1036
29. Ritchie, R. F.; Palomaki, G. E.; Neveux, L. M.; Navolotskaia, O.; Ledue, T. B.; Craig, W. Y. Reference distributions for the positive acute phase serum proteins, α1-acid glycoprotein (orosomucoid), α1-antitrypsin, and haptoglobin: A practical, simple, and clinically relevant approach in a large cohort J. Clin. Lab. Anal. 2000, 14 (6) 284-292
30. Blankley, R. T.; Fisher, C.; Westwood, M.; North, R.; Baker, P. N.; Walker, M. J.; Williamson, A.; Whetton, A. D.; Lin, W.; McCowan, L.; Roberts, C. T.; Cooper, G. J. S.; Unwin, R. D.; Myers, J. E. A label-free SRM workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia Mol. Cell. Proteomics 2013, 12 (11) 3148-3159
31. Tonack, S.; Jenkinson, C.; Cox, T.; Elliott, V.; Jenkins, R. E.; Kitteringham, N. R.; Greenhalf, W.; Shaw, V.; Michalski, C. W.; Friess, H.; Neoptolemos, J. P.; Costello, E. iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance Br. J. Cancer 2013, 108 (9) 1846-1853
32. Sun, D.; Zhang, H.; Guo, D.; Sun, A.; W, H. Shotgun Proteomic Analysis of Plasma from Dairy Cattle Suffering from Footrot: Characterization of Potential Disease-Associated Factors PLoS One 2013, 8 (2) e55973
33. Millioni, R.; Tolin, S.; Puricelli, L.; Sbrignadello, S.; Fadini, G. P.; Tessari, P.; Giorgio, A. High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity PLoS One 2011, 6 (5) e19603
34. Govorukhina, N. I.; Keizer-Gunnink, A.; van der Zee, A. G. J.; de Jong, S.; de Bruijn, H. W. A.; Bischoff, R. Sample preparation of human serum for the analysis of tumor markers: Comparison of different approaches for albumin and γ-globulin depletion J. Chromatogr., A 2003, 1009 (1-2) 171-178
35. Govorukhina, N. I.; Reijmers, T. H.; Nyangoma, S. O.; van der Zee, A. G. J.; Jansen, R. C.; Bischoff, R. Analysis of human serum by liquid chromatography-mass spectrometry: Improved sample preparation and data analysis J. Chromatogr., A 2006, 1120 (1-2) 142-150
36. Roche, S.; Tiers, L.; Provansal, M.; Seveno, M.; Piva, M.-T.; Jouin, P.; Lehmann, S. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: The more the better? J. Proteomics 2009, 72 (6) 945-951
37. Gong, Y.; Li, X.; Yang, B.; Ying, W.; Li, D.; Zhang, Y.; Dai, S.; Cai, Y.; Wang, J.; He, F.; Qian, X. Different Immunoaffinity Fractionation Strategies to Characterize the Human Plasma Proteome J. Proteome Res. 2006, 5 (6) 1379-1387
38. Dekker, L. J.; Bosman, J.; Burgers, P. C.; van Rijswijk, A.; Freije, R.; Luider, T.; Bischoff, R. Depletion of high-abundance proteins from serum by immunoaffinity chromatography: A MALDI-FT-MS study J. Chromatogr., B 2007, 847 (1) 65-69
39. Ruhaak, L. R.; Koeleman Carolien, A. M.; Uh, H.-W.; Stam, J. C.; van Heemst, D.; Maier, A. B.; Houwing-Duistermaat, J. J.; Hensbergen, P. J.; Slagboom, E. P.; Deelder, A. M.; Manfred, W. Targeted Biomarker Discovery by High Throughput Glycosylation Profiling of Human Plasma Alpha1-Antitrypsin and Immunoglobulin A PLoS One 2013, 8 (9) e73082
40. Chandler, K. B.; Pompach, P.; Goldman, R.; Edwards, N. Exploring Site-Specific N-Glycosylation Microheterogeneity of Haptoglobin Using Glycopeptide CID Tandem Mass Spectra and Glycan Database Search J. Proteome Res. 2013, 12 (8) 3652-3666
41. Bicho, M. C.; Silva, A. P. d.; Medeiros, R.; Bicho, M. Role of Haptoglobin and Its Genetic Polymorphism in Cancer: A Review. In Acute Phase Proteins; Janciauskiene, S., Ed.; InTech, 2013.
42. Ahn, Y. H.; Shin, P. M.; Kim, Y.-S.; Oh, N. R.; Ji, E. S.; Kim, K. H.; Lee, Y. J.; Kim, S. H.; Yoo, J. S. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry Analyst 2013, 138 (21) 6454-6462
43. Bertaccini, D.; Vaca, S.; Carapito, C.; Arsène-Ploetze, F.; Van Dorsselaer, A.; Schaeffer-Reiss, C. An Improved Stable Isotope N-Terminal Labeling Approach with Light/Heavy TMPP To Automate Proteogenomics Data Validation: dN-TOP J. Proteome Res. 2013, 12 (6) 3063-3070
44. Avall Lundqvist, E.; Blad, E.; Xiao, L.; Sjövall, K.; Eneroth, P. Pretreatment serum levels of C-reactive protein, alpha 1-antitrypsin, haptoglobin, alpha 1-acid glycoprotein and tissue polypeptide antigen in cervical carcinoma Eur. J. Gynaecol. Oncol. 1991, 12 (5) 375-383
45. Battaglia, F.; Scambia, G.; Panici, P. B.; Castelli, M.; Ferrandina, G.; Foti, E.; Amoroso, M.; DAndrea, G.; Mancuso, S. Immunosuppressive Acidic Protein (IAP) and Squamous Cell Carcinoma Antigen (SCC) in Patients with Cervical Cancer Gynecol. Oncol. 1994, 53 (2) 176-182
46. Chang, Y.-H.; Lee, S.-H.; Liao, I.-C.; Huang, S.-H.; Cheng, H.-C.; Liao, P.-C. Secretomic Analysis Identifies Alpha-1 Antitrypsin (A1AT) as a Required Protein in Cancer Cell Migration, Invasion, and Pericellular Fibronectin Assembly for Facilitating Lung Colonization of Lung Adenocarcinoma Cells Mol. Cell. Proteomics 2012, 11 (11) 1320-1339
47. Piva, M.; Horowitz, G. M.; Sharpe-Timms, K. L. Interleukin-6 Differentially Stimulates Haptoglobin Production by Peritoneal and Endometriotic Cells in Vitro: A Model for Endometrial-Peritoneal Interaction in Endometriosis J. Clin. Endocrinol. Metabol. 2001, 86 (6) 2553-2561
48. Mahmud, S. M.; Koushik, A.; Duarte-Franco, E.; Costa, J.; Fontes, G.; Bicho, M.; Coutlée, F.; Franco, E. L. Haptoglobin phenotype and risk of cervical neoplasia: A case-control study Clin. Chim. Acta 2007, 385 (1-2) 67-72
49. Quaye, I. K.; Agbolosu, K.; Ibrahim, M.; Bannerman-Williams, P. Haptoglobin phenotypes in cervical cancer: Decreased risk for Hp2-2 individuals Clin. Chim. Acta 2009, 403 (1-2) 267-268
50. Pal, D.; Dasgupta, S.; Kundu, R.; Maitra, S.; Das, G.; Mukhopadhyay, S.; Ray, S.; Majumdar, S. S.; Bhattacharya, S. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance Nat. Med. 2012, 18 (8) 1279-1285
51. Sakwe, A. M.; Koumangoye, R.; Goodwin, S. J.; Ochieng, J. Fetuin-A (α2HS-Glycoprotein) Is a Major Serum Adhesive Protein That Mediates Growth Signaling in Breast Tumor Cells J. Biol. Chem. 2010, 285 (53) 41827-41835
52. Thyer, L.; Ward, E.; Smith, R.; Branca, J. J. V.; Morucci, G.; Gulisano, M.; Noakes, D.; Eslinger, R.; Pacini, S. GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients OncoImmunology 2013, 2 (8) e25769
53. Yamamoto, N.; Naraparaju, V. R.; Asbell, S. O. Deglycosylation of Serum Vitamin D3-binding Protein Leads to Immunosuppression in Cancer Patients Cancer Res. 1996, 56 (12) 2827-2831
54. Aggarwal, B. B.; Shishodia, S.; Sandur, S. K.; Pandey, M. K.; Sethi, G. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 2006, 72 (11) 1605-1621
55. Vizcaino, J. A.; Deutsch, E. W.; Wang, R.; Csordas, A.; Reisinger, F.; Rios, D.; Dianes, J. A.; Sun, Z.; Farrah, T.; Bandeira, N.; Binz, P.-A.; Xenarios, I.; Eisenacher, M.; Mayer, G.; Gatto, L.; Campos, A.; Chalkley, R. J.; Kraus, H.-J.; Albar, J. P.; Martinez-Bartolome, S.; Apweiler, R.; Omenn, G. S.; Martens, L.; Jones, A. R.; Hermjakob, H. ProteomeXchange provides globally coordinated proteomics data submission and dissemination Nat. Biotechnol. 2014, 32 (3) 223-226